systém minisilk ft
deka m.e.l.a. srl. via baldanzese 17 500 41 calenzano taliansko -
šošovka vnútroočná pod ft 49p
physiol s.a. liége science park, allée des noisetiers 4 liége belgicko -
plerixafor onkogen 20 mg/ml injekčný roztok
onkogen kft., maďarsko - plerixafor - 59 - immunopraeparata
šošovka vnútroočná pod ft 49p
physiol s.a. liége science park, allée des noisetiers 4 liége belgicko -
meropeném steriscience 1 000 mg prášok na injekčný/infúzny roztok
steriscience b.v., holandsko - meropeném - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
meropeném steriscience 500 mg prášok na injekčný/infúzny roztok
steriscience b.v., holandsko - meropeném - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
advil rapid
glaxosmithkline consumer healthcare czech republic s.r.o., Česká republika - ibuprofén - 29 - antirheumatica, antiphlogistica, antiuratica
eucreas
novartis europharm limited - vildagliptin, hydrochlorid metformín - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, hydrochlorid metformín - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 a 5. 1 pre dostupné údaje o rôznych kombináciách).
zomarist
novartis europharm limited - vildagliptin, hydrochlorid metformín - diabetes mellitus, typ 2 - lieky používané pri cukrovke - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.